NCT03095352 Pembrolizumab With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease Status COMPLETED Phase PHASE2
NCT03093350 TACTIC - TAA Specific Cytotoxic T Lymphocytes in Patients With Breast Cancer Status COMPLETED Phase PHASE2
NCT03092635 AGE Levels in ER+ Metastatic Breast Cancer Patients Receiving Endocrine Therapy Status TERMINATED Phase PHASE1
NCT03089502 Efficacy of Cardio-Oncology Rehabilitation Exercise for Women With Breast Cancer and Treatment Related Cardiotoxicity Status TERMINATED Phase NA
NCT03087461 Bridging the Gap: Incorporating Exercise Evidence Into Clinical Practice in Breast Cancer Care in Ontario Status COMPLETED Phase NA
NCT03084939 Efficacy and Safety of Trastuzumab Emtansine in Chinese Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT03084536 PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery Status COMPLETED Phase PHASE2
NCT03084237 Compare Efficacy, Safety and Immunogenicity of HLX02 and Herceptin in Previously Untreated HER2 +Overexpressing Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT03083314 Selective Axillary Lymph Node Dissection Vs Complete Axillary Dissection: A Randomised Clinical Trial to Assess the Prevention of Lymphedema in Breast Cancer Treatment Status COMPLETED Phase NA
NCT03083288 Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03081507 Muslim Americans Reaching for Health and Building Alliances (MARHABA): Patient Navigation Intervention to Increase Breast and Cervical Cancer Screening Among Muslim Women in New York City Status COMPLETED Phase NA
NCT03081234 Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- Intermediate Risk Early Breast Cancer Status WITHDRAWN Phase PHASE3
NCT03080155 Evaluation of a Three Dimensional Functional Metabolic Imaging and Risk Assessment System in Classifying Women for Likelihood of Breast Cancer Status UNKNOWN Phase NA
NCT03079219 Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Chinese Breast Cancer Patients Status COMPLETED Phase PHASE3
NCT03078751 Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer Status COMPLETED Phase PHASE2
NCT03078036 International Breast Cancer Biomarker,Standard of Care and Real World Outcomes Study Status COMPLETED Phase N/A
NCT03077191 Toxicity and Outcome of Whole Breast Hypofractionated Radiotherapy: a Single Institution Experience Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03076190 My Surgical Success: A Randomized Controlled Pilot Study of a Pre-surgical Psychological Intervention Status COMPLETED Phase NA